Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

ResMed Inc. RMD

Healthcare  —  Medical Instruments & Supplies
222.00 0.11 0.05% as of 25 Sep
Market cap
$31.9B
P/E
21.3×
S&P 500 Member Dividend Champion (10y) Cash Flow Champion (3y) Revenue Champion (10y)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

ResMed Inc. (RMD) EV/EBITDA

As of 25 September 2026, ResMed Inc. (RMD) trades at a EV/EBITDA of 14.7×. Over the past ten years it has ranged from 11.7× (June 2026) to 39.8× (September 2021); the current reading is higher than 4% of that period. That is below the Medical Instruments & Supplies industry median of 16.1× and above the Healthcare sector median of 10.4×.

EV/EBITDA, daily

Annual

Period EV/EBITDA Change
FY2026 12.8× (34.04%)
FY2025 19.4× 6.74%
FY2024 18.2× (27.31%)
FY2023 25.0× (3.94%)
FY2022 26.1× (21.11%)
FY2021 33.0× 15.19%
FY2020 28.7× 11.20%
FY2019 25.8× 14.54%
FY2018 22.5× 7.50%
FY2017 20.9× 19.88%

Quarterly

Period EV/EBITDA Change
Jun 2026 12.8× (11.98%)
Mar 2026 14.6× (11.92%)
Dec 2025 16.5× (16.03%)
Sep 2025 19.7× 1.33%
42 more quarters

Against its own ten years

Low 11.7× High 39.8×
Ten-year median 21.7×
Current reading's percentile 4

EV/EBITDA against peers

Company EV/EBITDA
MDLN Medline Inc. compare 3.9×
SOLV Solventum Corporation compare 7.9×
ALC Alcon compare 12.7×
BDX Becton, Dickinson and Company compare 13.3×
BAX Baxter International Inc. compare 13.3×
COO The Cooper Companies, Inc. compare 14.1×
RMD ResMed Inc. 14.7×
WST West Pharmaceutical Services, Inc. compare 30.2×
RGEN Repligen Corporation compare 65.3×
Medical Instruments & Supplies industry median 16.1×
Healthcare sector median 10.4×
Market median 11.0×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on RMD